2-Methoxyestradiol reverses doxorubicin resistance in human breast tumor xenograft

Cancer Chemotherapy and Pharmacology

Volumn 62, Issue 5, 2008, Pages 893-902

  Azab, Samar S ^a,b   Salama, Salama A ^a   Hassan, Memy H ^a   Khalifa, Amani E ^b   El Demerdash, Ebtehal ^b   Fouad, Hala ^a   Al Hendy, Ayman ^c   Abdel Naim, Ashraf B ^d  

^a University of Texas Medical Branch School of Medicine   (United States)

^b Ain Shams University   (Egypt)

^c Nashville General Hospital at Meharry   (United States)

^d KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

2 Methoxyestradiol; Doxorubicin; Drug resistance

Indexed keywords

2 METHOXYESTRADIOL; CYCLINE; DOXORUBICIN; DRUG VEHICLE; KI 67 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST TUMOR; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR VOLUME; TUMOR XENOGRAFT;

ALGORITHMS; ANGIOGENESIS INHIBITORS; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BODY WEIGHT; BREAST NEOPLASMS; CELL PROLIFERATION; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; ESTRADIOL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; LIVER; MICE; MICE, INBRED BALB C; MICE, NUDE; MYOCARDIUM; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 49749145306     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-008-0679-9     Document Type: Article

References (34)

1. P Chaudhary I Roninson 1993 Induction of multi-drug resistance in human cells by transient exposure to different chemotherapeutic drugs J Natl Cancer Inst 85 632 639
2. D Chauhan L Catley T Hideshima G Li R Leblanc D Gupta M Sattler P Richardson R Schlossman K Podar E Weller N Munshi K Anderson 2002 2-Methoxyestradiol overcomes drug resistance in multiple myeloma cells Blood 100 6 2187 2194
3. J Chen M Konopleva M Andreeff A Multani S Pathak K Mehta 2004 Drug-resistant breast carcinoma (MCF-7) cells are paradoxically sensitive to apoptosis J Cell Physiol 200 2 223 234
4. R D'Amato C Lin E Flynn J Folkman E Hamel 1994 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicines site Proc Natl Acad Sci USA 91 3964 3968
5. D Dingli M Timm S Russell T Witzing S Rajkumar 2002 Promising preclinical activity of 2-methoxyestradiol in multiple myeloma Clin Cancer Res 8 3948 3954
6. J Dobos J Tímár J Bocsi Z Burián K Nagy G Barna I Peták A Ladányi 2004 In vitro and in vivo antitumor effect of 2-methoxyestradiol on human melanoma Int J Cancer 112 5 771 776
7. T Fostis Y Zhang M Pepper H Adlercreutz R Montesano P Nawroth L Schweigerer 1994 The endogenous oestrogen metabolite 2-methoxyestradiol inhibits angiogenesis and suppresses tumour growth Nature 368 237 239
8. G Han Z Liu K Shimoi B Zhu 2005 Synergism between the anticancer actions of 2-methoxyestradiol and microtubule-disrupting agents in human breast cancer Cancer Res 65 2 387 393
9. C Herzog M Tsokos S Bates A Fojo 1993 Increased mdr-1/P-glycoprotein expression after treatment of human colon carcinoma cells with P-glycoprotein antagonists J Biol Chem 268 2946 2952
10. C Ireson S Chander A Purohit S Perera S Newman D Parish M Leese A Smith B M Potter Reed 2004 Pharmacokinetics and efficacy of 2-methoxyestradiol and 2-methoxoestradiol-bis-sulphamate in vivo in rodents Br J Cancer 90 932 937
11. H Ishida M Okabe K Gomi R Horiuchi K Mikami M Naito T Tsuruo 1994 Modulation of adriamycin resistance in human breast carcinoma MCF-7 cells in vitro and in vivo by medroxyprogesterone acetate Jpn J Cancer Res 85 542 549
12. R Kerb S Hoffmeyer U Brinkmann 2001 ABC drug transporters: hereditary polymorphism and pharmacological impact in MDR1, MRP1 and MRP2 Pharmacogenomics 2 51 64
13. N Klauber S Parangi E Flynn E Hamel R D'Amato 1997 Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol Cancer Res 57 81 86
14. R Leonard A Rodger J Dixon 1994 Metastatic breast cancer Br Med J 309 1501 1504
15. L Li J Da M Landstrom U Ulmsten X Fu 2005 Antiproliferative activity and toxicity of 2-methoxyestradiol in cervical cancer xenograft mice Int J Gynecol Cancer 15 301 307
16. V Ling 1997 Multidrug resistance: molecular mechanisms and clinical relevance Cancer Chemother Pharmacol 40 suppl S3 S10
17. L MacCarthy-Morrogh P Townsend A Purohit H Hejaz B Potter M Reed G Packham 2000 Differentical effects of estrone and estrone-3-O-sulphamate derivatives on mitotic arrest, apoptosis and microtubule assembly in human breast cancer cells Cancer Res 60 5441 5550
18. D McCormick W Johnson V Pribluda S Green J Tomaszewski A Smith 2000 Preclinical development of 2-methoxyestradiol (2ME2, NSC-659853). [Abstract] Proc Am Assoc Cancer Res 41 328
19. E Mimnaugh C Faichild J Fruehauf B Sinha 1991 Biochemical and pharmacological characterization of MCF-7 drug sensitive and Adr multidrug-resistant human breast tumor xenografts in athymic nude mice Biochem Pharmacol 42 2 391-402
20. K Mehta 1994 High levels of transglutaminase expression in doxorubicin resistant human breast carcinoma cells Int J Cancer 58 400 406
21. G Merriam N MacLusky M Picard F Naftolin 1980 Comparative properties of the catechol estrogens, I: methylation by catechol-O-methyl-transferase and binding to cytosol estrogen receptors Steroids 36 1 11
22. S Mooberry 2003 New insights into 2-methoxyestradio, a promising antiangiogenic and antitumor agent Curr Opin Oncol 15 425 430
23. A Mueck H Seeger J Huober 2004 Chemotherapy of breast cancer-additive anticancerogenic effects by 2-methoxyestradiol? Life Sci 75 10 1205 1210
24. R O'Connor 2007 The pharmacology of cancer resistance Anticancer Res 27 3A 1267 1272
25. Pribluda V, LaVallee T, Green S (2002) 2-Methoxyestradiol: a novel endogenous chemotherapeutic and anti-angiogenic agent. In: Fan T-PD, Kohn E (eds) The new angiotherapy. Humana Press, Totawa, pp 387-408
26. E Ryschich J Werner M Gebhard E Klar J Schmidt 2003 Angiogenesis inhibition with TNP-470, 2-methoxyestradil, and paclitaxel in experimental pancreatic carcinoma Pancreas 26 166 172
27. T Sutherland M Schuliga T Harris B Eckhardt R Anderson L Quan A Stewart 2005 2-Methoxyestradiol is an estrogen receptor agonist that supports tumor growth in murine xenograft models of breast cancer Clinical Cancer Res 11 1722 1732
28. T Tinley R Leal D Randall-Hlubek J Cessac L Wilkens P Rao S Mooberry 2003 Novel 2-methoxyestradiol analogues with antitumor activity Cancer Res 63 1538 1549
29. C Ulmann H Eliot B Sinha 1991 Distibution, DNA damage and cytotoxic effects of etoposide in human tumor xenografts in vivo Anticancer Res 11 1379 1382
30. V Vijayanathan S Venkiteswaran S Nair A Verma T Thomas B Zhu T Thomas 2006 Physiologic levels of 2-methoxyestradiol interfere with nongenomic signaling of 17beta-estradiol in human breast cancer cells Clin Cancer Res 12 7 Pt 1 2038 2048
31. L Wang C Yang S Horwitz P Trail A Casazza 1994 Reversal of the human and murine multidrug-resistance phenotype with megestrol acetate Cancer Chemother Pharmacol 34 96 102
32. R Wild S Ramakrishnan J Sedgewick A Griffioen 2000 Quantitative assessment of angiogenesis and tumor vessel architecture by computer-assisted digital image analysis: effects of VEGF-toxin conjugate on tumor microvessel density Microvasc Res 59 368 376
33. D Von Hoff M Rozencweig M Piccat 1982 The cardiotoxicity of anticancer agents Semin Oncol 9 23 33
34. X Yi R Bekeredjian N DeFilippis Z Siddiquee E Fernandez R Shohet 2006 Transcriptional analysis of doxorubicin-induced cardiotoxicity Am J Physiol Heart Circ Physiol 290 3 H1098 102